(Q48035577)

English

Expression of cyclooxygenase-2 in association with clinicopathological prognostic factors and molecular markers in epithelial ovarian cancer.

scientific article published in March 2004

In more languages

Statements

scholarly article

1 reference

7 February 2018

http://europepmc.org/abstract/MED/14984962

Expression of cyclooxygenase-2 in association with clinicopathological prognostic factors and molecular markers in epithelial ovarian cancer. (English)

1 reference

7 February 2018

http://europepmc.org/abstract/MED/14984962

1 reference

based on heuristic

inferred from title

5

object named as

Yung Jue Bang

1 reference

7 February 2018

http://europepmc.org/abstract/MED/14984962

author name string

Sang Soo Seo

1

1 reference

7 February 2018

http://europepmc.org/abstract/MED/14984962

Yong Sang Song

2

1 reference

7 February 2018

http://europepmc.org/abstract/MED/14984962

Dae-hee Kang

3

1 reference

7 February 2018

http://europepmc.org/abstract/MED/14984962

In Ae Park

4

1 reference

7 February 2018

http://europepmc.org/abstract/MED/14984962

Soon Beom Kang

6

1 reference

7 February 2018

http://europepmc.org/abstract/MED/14984962

Hyo Pyo Lee

7

1 reference

7 February 2018

http://europepmc.org/abstract/MED/14984962

language of work or name

0 references

publication date

1 March 2004

1 reference

7 February 2018

http://europepmc.org/abstract/MED/14984962

Gynecologic Oncology

1 reference

7 February 2018

http://europepmc.org/abstract/MED/14984962

92

1 reference

7 February 2018

http://europepmc.org/abstract/MED/14984962

927-935

1 reference

7 February 2018

http://europepmc.org/abstract/MED/14984962

3

1 reference

7 February 2018

http://europepmc.org/abstract/MED/14984962

The role of neoadjuvant chemotherapy and interval laparotomy in advanced ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.11.055

7 January 2021

Cyclooxygenases 1 and 2

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.11.055

7 January 2021

Possible role of ovarian epithelial inflammation in ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.11.055

7 January 2021

Ovarian cancer and talc: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.11.055

7 January 2021

Role of oxygen free radicals in cancer development

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.11.055

7 January 2021

Cyclooxygenase-2 pathway correlates with VEGF expression in head and neck cancer. Implications for tumor angiogenesis and metastasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.11.055

7 January 2021

Present medical management of Barrett's oesophagus

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.11.055

7 January 2021

Gastroduodenal lesions in familial adenomatous polyposis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.11.055

7 January 2021

Cyclooxygenase (COX)-2 immunoreactivity and relationship to p53 and Ki-67 expression in colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.11.055

7 January 2021

The role of cyclooxygenases in inflammation, cancer, and development

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.11.055

7 January 2021

High cyclooxygenase-2 expression in stage IB cervical cancer with lymph node metastasis or parametrial invasion

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.11.055

7 January 2021

Tumor invasiveness and liver metastasis of colon cancer cells correlated with cyclooxygenase-2 (COX-2) expression and inhibited by a COX-2-selective inhibitor, etodolac.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.11.055

7 January 2021

Depth of invasion parallels increased cyclooxygenase-2 levels in patients with gastric carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.11.055

7 January 2021

Relation between cyclooxygenase-2 expression and tumor invasiveness and patient survival in transitional cell carcinoma of the urinary bladder.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.11.055

7 January 2021

Expression of cyclooxygenase-2 in the subserosal layer correlates with postsurgical prognosis of pathological tumor stage 2 carcinoma of the gallbladder

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.11.055

7 January 2021

Elevated cyclooxygenase-2 expression correlates with diminished survival in carcinoma of the cervix treated with radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.11.055

7 January 2021

Cyclooxygenase-2 (COX-2), epidermal growth factor receptor (EGFR), and Her-2/neu expression in ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.11.055

7 January 2021

Association between acetaminophen or nonsteroidal antiinflammatory drugs and risk of developing ovarian, breast, or colon cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.11.055

7 January 2021

Is COX-2 inhibition a panacea for cancer prevention?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.11.055

7 January 2021

Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.11.055

7 January 2021

Cyclooxygenase 2: a molecular target for cancer prevention and treatment

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.11.055

7 January 2021

Expression of prostaglandin G/H synthase type 1, but not type 2, in human ovarian adenocarcinomas

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.11.055

7 January 2021

Expression of cyclooxygenase 2 is an independent prognostic factor in human ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.11.055

7 January 2021

Prognostic significance of p53 and p21(waf1/cip1) immunoreactivity in epithelial cancers of the ovary

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.11.055

7 January 2021

p21 and p53 in ovarian carcinoma: their combined staining is more valuable than either alone.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.11.055

7 January 2021

Inhibition of cyclooxygenase-2 gene expression by p53.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.11.055

7 January 2021

Vascular endothelial growth factor expression in serous ovarian carcinoma: relationship with high mitotic activity and high FIGO stage

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.11.055

7 January 2021

Survival among U.S. women with invasive epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.11.055

7 January 2021

Heterogeneity of ovarian cancer: relationships among histological group, stage of disease, tumor markers, patient characteristics, and survival

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.11.055

7 January 2021

Expression of nitric oxide synthase, cyclooxygenase, and p53 in different stages of human gastric cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.11.055

7 January 2021

Association between cyclo-oxygenase-2 overexpression and missense p53 mutations in gastric cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.11.055

7 January 2021

P53-mediated induction of Cox-2 counteracts p53- or genotoxic stress-induced apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.11.055

7 January 2021

Prognostic significance of microvessel density, vascular cuffing and vascular endothelial growth factor expression in ovarian carcinoma: a special review for clear cell adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.11.055

7 January 2021

VEGF expression and enhanced production by gonadotropins in ovarian epithelial tumors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.11.055

7 January 2021

Identifiers

10.1016/J.YGYNO.2003.11.055

1 reference

7 February 2018

http://europepmc.org/abstract/MED/14984962

1 reference

7 February 2018

http://europepmc.org/abstract/MED/14984962

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48035577&oldid=2095136232"